Jay F. Davies

2.5k total citations
17 papers, 1.7k citations indexed

About

Jay F. Davies is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Jay F. Davies has authored 17 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in Jay F. Davies's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (5 papers) and Chemical Synthesis and Analysis (4 papers). Jay F. Davies is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (5 papers) and Chemical Synthesis and Analysis (4 papers). Jay F. Davies collaborates with scholars based in United States. Jay F. Davies's co-authors include Zuzana Hostomska, Zdeněk Hostomský, David A. Matthews, Steven R. Jordan, Joseph Kraut, Siegfried Reich, Krzysztof Appelt, Robert J. Almassy, Rose Ann Ferre and Neal J. Prendergast and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jay F. Davies

16 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay F. Davies United States 14 985 616 456 417 170 17 1.7k
Wayne K. Herber United States 13 926 0.9× 612 1.0× 555 1.2× 200 0.5× 125 0.7× 21 1.6k
Brian M. McKeever United States 24 1.4k 1.4× 731 1.2× 617 1.4× 615 1.5× 174 1.0× 46 2.5k
Leigh Clawson United States 7 874 0.9× 885 1.4× 800 1.8× 560 1.3× 169 1.0× 8 1.8k
Luciano Cellai Italy 21 676 0.7× 319 0.5× 238 0.5× 215 0.5× 146 0.9× 83 1.3k
Stephanie A. Leavitt United States 17 837 0.8× 399 0.6× 214 0.5× 154 0.4× 104 0.6× 20 1.6k
William E. Kohlbrenner United States 19 774 0.8× 924 1.5× 695 1.5× 521 1.2× 65 0.4× 34 1.9k
Paul A. Aristoff United States 23 978 1.0× 546 0.9× 340 0.7× 717 1.7× 55 0.3× 49 2.1k
Andrew Prongay United States 21 711 0.7× 443 0.7× 293 0.6× 246 0.6× 68 0.4× 43 1.6k
Jill C. Heimbach United States 7 958 1.0× 1.6k 2.6× 1.5k 3.3× 423 1.0× 136 0.8× 10 2.3k
K. E. B. PARKES United Kingdom 15 632 0.6× 640 1.0× 513 1.1× 400 1.0× 47 0.3× 32 1.4k

Countries citing papers authored by Jay F. Davies

Since Specialization
Citations

This map shows the geographic impact of Jay F. Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay F. Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay F. Davies more than expected).

Fields of papers citing papers by Jay F. Davies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay F. Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay F. Davies. The network helps show where Jay F. Davies may publish in the future.

Co-authorship network of co-authors of Jay F. Davies

This figure shows the co-authorship network connecting the top 25 collaborators of Jay F. Davies. A scholar is included among the top collaborators of Jay F. Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay F. Davies. Jay F. Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kung, Pei‐Pei, Buwen Huang, Gang Zhang, et al.. (2009). Dihydroxyphenylisoindoline Amides as Orally Bioavailable Inhibitors of the Heat Shock Protein 90 (Hsp90) Molecular Chaperone. Journal of Medicinal Chemistry. 53(1). 499–503. 64 indexed citations
2.
Kung, Pei‐Pei, Lee Funk, Jerry Meng, et al.. (2008). Dihydroxylphenyl amides as inhibitors of the Hsp90 molecular chaperone. Bioorganic & Medicinal Chemistry Letters. 18(23). 6273–6278. 38 indexed citations
3.
Beardsley, G. Peter, Elizabeth A. Rayl, Barbara A. Moroson, et al.. (1998). Structure and Functional Relationships in Human pur H. Advances in experimental medicine and biology. 431. 221–226. 28 indexed citations
4.
Kaldor, Stephen W., Vincent J. Kalish, Jay F. Davies, et al.. (1997). Viracept (Nelfinavir Mesylate, AG1343):  A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease. Journal of Medicinal Chemistry. 40(24). 3979–3985. 483 indexed citations
5.
Reich, Siegfried, Michael Melnick, Mary Ann M. Fuhry, et al.. (1996). Structure-Based Design and Synthesis of Substituted 2-Butanols as Nonpeptidic Inhibitors of HIV Protease:  Secondary Amide Series. Journal of Medicinal Chemistry. 39(14). 2781–2794. 38 indexed citations
6.
Melnick, Michael, Siegfried Reich, Anthony J. Trippe, et al.. (1996). ChemInform Abstract: Bis Tertiary Amide Inhibitors of the HIV‐1 Protease Generated via Protein Structure‐Based Iterative Design.. ChemInform. 27(43).
7.
Melnick, Michael, Siegfried Reich, Anthony J. Trippe, et al.. (1996). Bis Tertiary Amide Inhibitors of the HIV-1 Protease Generated via Protein Structure-Based Iterative Design. Journal of Medicinal Chemistry. 39(14). 2795–2811. 27 indexed citations
8.
Reich, Siegfried, Michael Melnick, Mary Ann M. Fuhry, et al.. (1996). ChemInform Abstract: Structure‐Based Design and Synthesis of Substituted 2‐Butanols as Nonpeptidic Inhibitors of HIV Protease: Secondary Amide Series.. ChemInform. 27(43). 1 indexed citations
9.
Reich, Siegfried, Michael Melnick, Jay F. Davies, et al.. (1995). Protein structure-based design of potent orally bioavailable, nonpeptide inhibitors of human immunodeficiency virus protease.. Proceedings of the National Academy of Sciences. 92(8). 3298–3302. 38 indexed citations
10.
Kalish, Vincent J., Stephen W. Kaldor, Bhasker V. Shetty, et al.. (1995). ITERATIVE PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF HIV PROTEASE INHIBITORS. European Journal of Medicinal Chemistry. 30. 201s–214s. 21 indexed citations
11.
Kalish, Vincent J., John H. Tatlock, Jay F. Davies, et al.. (1995). Structure-based drug design of nonpeptidic P2 substituents for HIV-1 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 5(7). 727–732. 12 indexed citations
12.
Davies, Jay F., Robert J. Almassy, Zuzana Hostomska, Rose Ann Ferre, & Zdeněk Hostomský. (1994). 2.3 Å crystal structure of the catalytic domain of DNA polymerase β. Cell. 76(6). 1123–1133. 152 indexed citations
13.
McTigue, Michele, Jay F. Davies, Bernard T. Kaufman, & J. Kraut. (1993). Crystal structures of chicken liver dihydrofolate reductase: Binary thioNADP+ and ternary thioNADP+.cntdot.biopterin complexes. Biochemistry. 32(27). 6855–6862. 22 indexed citations
14.
McTigue, Michele, Jay F. Davies, Bernard T. Kaufman, & Joseph Kraut. (1992). Crystal structure of chicken liver dihydrofolate reductase complexed with NADP+ and biopterin. Biochemistry. 31(32). 7264–7273. 61 indexed citations
15.
Hostomska, Zuzana, David A. Matthews, Jay F. Davies, B R Nodes, & Zdeněk Hostomský. (1991). Proteolytic release and crystallization of the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase. Journal of Biological Chemistry. 266(22). 14697–14702. 29 indexed citations
16.
Davies, Jay F., Zuzana Hostomska, Zdeněk Hostomský, Steven R. Jordan, & David A. Matthews. (1991). Crystal Structure of the Ribonuclease H Domain of HIV-1 Reverse Transcriptase. Science. 252(5002). 88–95. 495 indexed citations
17.
Davies, Jay F., Tavner J. Delcamp, Neal J. Prendergast, et al.. (1990). Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate. Biochemistry. 29(40). 9467–9479. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wayne K. Herber Breakdown of academic impact, for papers by Brian M. McKeever Breakdown of academic impact, for papers by Leigh Clawson Breakdown of academic impact, for papers by Luciano Cellai Breakdown of academic impact, for papers by Stephanie A. Leavitt Breakdown of academic impact, for papers by William E. Kohlbrenner Breakdown of academic impact, for papers by Paul A. Aristoff Breakdown of academic impact, for papers by Andrew Prongay Breakdown of academic impact, for papers by Jill C. Heimbach Breakdown of academic impact, for papers by K. E. B. PARKES
Rankless by CCL
2026